Globus Medical, Inc., based in Audubon, PA, is a medical device company focused on the design, development, and commercialization of musculoskeletal implants that promote healing in patients with spine disorders. It develops products that assist surgeons in effectively treating their patients, respond to evolving surgeon needs and address new treatment options. Globus Medical is a publicly traded company and is listed on the NYSE under the symbol GMED. The companys products are classified into two categories: Innovative Fusion and Disruptive Technologies. The Innovative Fusion products are uses in cervical, thoracolumbar, sacral, and interbody, corpectomy fusion procedures to treat degenerative, deformity, tumor, and trauma conditions. Globus Medical to date has developed a portfolio of spine products, releasing more than 150 products. October 23, 2014 Globus Medical acquired allograft tissue processor Transplant Technologies of Texas, Ltd. (TTOT). TTOT is a provider of human tissue products including bone allografts, biomaterials, and soft tissue products for spine, orthopedics, sports medicine, dental, and wound care markets.
Highest paying job titles at Globus Medical include International Tax Manager, Product Manager, and Senior Product Manager